A detailed history of Bank Of America Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Bank Of America Corp holds 503,856 shares of NVCR stock, worth $9.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
503,856
Previous 551,636 8.66%
Holding current value
$9.92 Million
Previous $9.45 Million 16.66%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.61 - $23.34 $745,845 - $1.12 Million
-47,780 Reduced 8.66%
503,856 $7.88 Million
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $8.32 Million - $16.9 Million
-703,495 Reduced 56.05%
551,636 $9.45 Million
Q1 2024

May 15, 2024

BUY
$12.42 - $17.29 $7.16 Million - $9.97 Million
576,519 Added 84.96%
1,255,131 $19.6 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $6.16 Million - $8.73 Million
553,197 Added 441.09%
678,612 $10.1 Million
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $9.2 Million - $18.8 Million
-228,364 Reduced 64.55%
125,415 $5.2 Million
Q1 2023

May 12, 2023

BUY
$56.44 - $118.81 $9.91 Million - $20.9 Million
175,581 Added 98.53%
353,779 $21.3 Million
Q4 2022

Feb 10, 2023

SELL
$63.98 - $85.37 $4.05 Million - $5.4 Million
-63,260 Reduced 26.2%
178,198 $13.1 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $4.93 Million - $6.5 Million
72,524 Added 42.93%
241,458 $18.3 Million
Q2 2022

Aug 12, 2022

SELL
$56.6 - $89.9 $1.74 Million - $2.76 Million
-30,660 Reduced 15.36%
168,934 $11.7 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $660,567 - $928,198
-10,982 Reduced 5.22%
199,594 $16.5 Million
Q4 2021

Feb 08, 2022

SELL
$75.08 - $121.99 $1.66 Million - $2.7 Million
-22,164 Reduced 9.52%
210,576 $15.8 Million
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $8.02 Million - $13.4 Million
69,013 Added 42.15%
232,740 $27 Million
Q2 2021

Sep 13, 2021

BUY
$130.4 - $225.58 $21.4 Million - $36.9 Million
163,727 New
163,727 $36.3 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.07B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.